Exact Mass: 367.1478

Exact Mass Matches: 367.1478

Found 38 metabolites which its exact mass value is equals to given mass value 367.1478, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Casuarine 6-alpha-D-glucoside

3-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1H-pyrrolizine-1,2,7-triol

C14H25NO10 (367.1478)


Casuarine 6-alpha-D-glucoside is found in fruits. Casuarine 6-alpha-D-glucoside is an alkaloid from Eugenia jambolana (jambolan

   

N-Acetyl-6-O-L-fucosyl-D-glucosamine

N-[(2R,3R,4S)-3,4,5-Trihydroxy-1-oxo-6-{[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-2-yl]ethanimidate

C14H25NO10 (367.1478)


N-Acetyl-6-O-L-fucosyl-D-glucosamine is an oligosaccharin obtained from human milk (Fiziologiya i Biokhimiya Kulturnykh Rastenii (2002), 34(1), 52-57) [HMDB] N-Acetyl-6-O-L-fucosyl-D-glucosamine is an oligosaccharin obtained from human milk (Fiziologiya i Biokhimiya Kulturnykh Rastenii (2002), 34(1), 52-57).

   

2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose

N-{3,4,5-trihydroxy-1-oxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]hexan-2-yl}ethanimidate

C14H25NO10 (367.1478)


2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose is an oligosaccharide isolated from the urine of patients with fucosidosis (Fucosidosis is an autosomal recessive lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues. Different phenotypes include clinical features such as neurologic deterioration, growth retardation, visceromegaly, and seizures in a severe early form; coarse facial features, angiokeratoma corporis diffusum, spasticity and delayed psychomotor development in a longer surviving form; and an unusual spondylometaphyseoepiphyseal dysplasia in yet another form. OMIM 230000). (PMID 728478) [HMDB] 2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose is an oligosaccharide isolated from the urine of patients with fucosidosis (Fucosidosis is an autosomal recessive lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues. Different phenotypes include clinical features such as neurologic deterioration, growth retardation, visceromegaly, and seizures in a severe early form; coarse facial features, angiokeratoma corporis diffusum, spasticity and delayed psychomotor development in a longer surviving form; and an unusual spondylometaphyseoepiphyseal dysplasia in yet another form. OMIM 230000). (PMID 728478).

   

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

N-[(2R,3R,4R,5R)-4,5,6-Trihydroxy-1-oxo-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-2-yl]ethanimidate

C14H25NO10 (367.1478)


3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose is an oligosaccharide is a fucosylated oligosaccharide specific to human, and in milk forms part of the innate immune system. (PMID: 1579031). It is present in a number of proteins, such as human transferrin. Hepatocytes contain a receptor that binds glycoproteins specifically through the fucose in alpha13 linkage to N-acetylglucosamine. (PMID: 276862). It is also present in some forms of human kidney enzyme alpha-L-fucosidase (EC 3.2.1.51) (PMID: 7215135). 3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose is an oligosaccharide is a fucosylated oligosaccharide specific to human, and in milk forms part of the innate immune system. (PMID: 1579031)

   
   

beta-D-GlcpNAc-(1-3)-L-Rha

beta-D-GlcpNAc-(1-3)-L-Rha

C14H25NO10 (367.1478)


   

N-Acetyl-6-O-L-fucosyl-D-glucosamine

2-(acetylamino)-2-Deoxy-6-O-(6-deoxy-L-galactopyranosyl)-D-glucose

C14H25NO10 (367.1478)


   

2-Acetamido-2-deoxy-6-O-a-L-fucopyranosyl-D-glucose

2-(acetylamino)-2-Deoxy-6-O-(6-deoxy-alpha-L-galactopyranosyl)-delta-glucose

C14H25NO10 (367.1478)


   

-O-Fucopyranosyl-2-acetamido-2-deoxyglucopyranose

2-(acetylamino)-2-Deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)- D-glucose

C14H25NO10 (367.1478)


   

Casuarine 6-a-D-glucoside

3-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1H-pyrrolizine-1,2,7-triol

C14H25NO10 (367.1478)


   

2-ACETAMIDO-2-DEOXY-3-O-(A-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

2-ACETAMIDO-2-DEOXY-3-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

2-ACETAMIDO-2-DEOXY-6-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

2-ACETAMIDO-2-DEOXY-6-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

2-Acetamido-2-deoxy-4-O-(a-L-fucopyranosyl)-D-glucopyranose

2-ACETAMIDO-2-DEOX-4-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

2-(acetylamino)-2-deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-glucopyranose

2-(acetylamino)-2-deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-glucopyranose

C14H25NO10 (367.1478)


   

alpha-L-fucosyl-(1->4)-N-acetyl-beta-D-glucosamine

alpha-L-fucosyl-(1->4)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->4)-glycosidic linkage.

   

N-((2S,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

N-((2S,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

N-((2R,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

N-((2R,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-((((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

N-((2S,3R,4R,5S,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

N-((2S,3R,4R,5S,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

C14H25NO10 (367.1478)


   

beta-D-GlcpNAc-(1->3)-alpha-L-Fucp

beta-D-GlcpNAc-(1->3)-alpha-L-Fucp

C14H25NO10 (367.1478)


   

Fuc(b1-6)b-GlcNAc

Fuc(b1-6)b-GlcNAc

C14H25NO10 (367.1478)


   

alpha-L-Rha-(1->3)-beta-D-GlcNAc

alpha-L-Rha-(1->3)-beta-D-GlcNAc

C14H25NO10 (367.1478)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having an alpha-L-rhamnosyl residue attached at the 3-position.

   

beta-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

beta-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of a beta-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->3)-glycosidic linkage.

   

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-alpha-D-rhamnopyranose

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-alpha-D-rhamnopyranose

C14H25NO10 (367.1478)


   

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-alpha-L-rhamnopyranose

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-alpha-L-rhamnopyranose

C14H25NO10 (367.1478)


   

beta-D-GlcpNAc-(1->3)-alpha-L-Rhap

beta-D-GlcpNAc-(1->3)-alpha-L-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of alpha-L-rhamnose having an N-acetyl beta-D-glucosaminyl residue attached at the 3-position.

   

Fuc(b1-3)a-GlcNAc

2-ACETAMIDO-2-DEOXY-3-O-(A-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE

C14H25NO10 (367.1478)


   

GlcNAc(b1-3)Fuc

GlcNAc(b1-3)Fuc

C14H25NO10 (367.1478)


   

Fuc(b1-6)a-GlcNAc

Fuc(b1-6)a-GlcNAc

C14H25NO10 (367.1478)


   

Fuc(a1-3)a-GlcNAc

Fuc(a1-3)a-GlcNAc

C14H25NO10 (367.1478)


   

GlcNAc(b1-3)b-Fuc

GlcNAc(b1-3)b-Fuc

C14H25NO10 (367.1478)


   

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

3-O-fucopyranosyl-2-acetamido-2-deoxyglucopyranose

C14H25NO10 (367.1478)


   

Casuarine 6-alpha-D-glucoside

Casuarine 6-alpha-D-glucoside

C14H25NO10 (367.1478)


   

beta-D-GlcpNAc-(1->2)-alpha-L-Rhap

beta-D-GlcpNAc-(1->2)-alpha-L-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of alpha-L-rhamnose having an N-acetyl beta-D-glucosaminyl residue attached at the 2-position.

   

beta-D-GlcpNAc-(1->4)-alpha-D-Rhap

beta-D-GlcpNAc-(1->4)-alpha-D-Rhap

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-D-rhamnos residue having an N-acetyl-beta-D-glucosaminyl residue attached at the 4-position.

   

alpha-L-Fucp-(1->3)-D-GlcpNAc

alpha-L-Fucp-(1->3)-D-GlcpNAc

C14H25NO10 (367.1478)


An amino disaccharide consisting of N-acetyl-D-glucosamine having an alpha-L-fucosyl residue attached at the 3-position.

   

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-glucosamine

C14H25NO10 (367.1478)


An amino disaccharide consisting of an alpha-L-fucosyl residue attached to N-acetyl-beta-Dglucosamine by a (1->3)-glycosidic linkage.

   

n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2s,3r,4s,5r,6r)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxy}oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2s,3r,4s,5r,6r)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxy}oxan-3-yl]ethanimidic acid

C14H25NO10 (367.1478)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-[(4,5,6-trihydroxy-2-methyloxan-3-yl)oxy]oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-[(4,5,6-trihydroxy-2-methyloxan-3-yl)oxy]oxan-3-yl]ethanimidic acid

C14H25NO10 (367.1478)